Jasper Therapeutics, Inc. (JSPR): Form 8-K filed 2026-11-13
- Accepted by EDGAR
- 2026-11-13 16:30 ET
- Event date
- 2026-11-13
- Accession no.
- 0001213900-26-119785
- Original filing
- SEC EDGAR filing index
AI summary of the filing text. It can contain mistakes; the original filing is authoritative.
Jasper Therapeutics adjourns special stockholder meeting due to lack of quorum
Jasper Therapeutics adjourned its November 13, 2026 special stockholder meeting without conducting any business because a quorum was not present. The meeting will reconvene virtually on December 1, 2026, at 10:00 a.m. Pacific Time. The record date and proposals remain unchanged.
- The November 13, 2026 special meeting was adjourned without conducting any business due to a lack of quorum.
- The meeting will reconvene virtually on December 1, 2026, at 10:00 a.m. Pacific Time.
- The record date remains the close of business on September 28, 2026.
- The proposals are unchanged; stockholders who already voted need not act unless they want to change their vote.
shareholder vote
Items reported
- Item 8.01: Other Events
A voluntary disclosure of an event the company considers important to security holders that no other Item covers, such as a dividend declaration, a buyback program, litigation updates or product news.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | CURRENT REPORT | ea0312169-8k_jasper.htm |
The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.